Post‐marketing safety concerns with nirmatrelvir: A disproportionality analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System
Article in British Journal of Clinical Pharmacology (May 2023)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in British Journal of Clinical Pharmacology (May 2023)
Article in Vaccines (February 2023)